4-Methylmorpholine → (S)-3-(3-phenylpropanoyl)-4-methyl-2,5-oxazolidinedione
Reaction equation
[CH3:1][C@H:2]1[C:6](=[O:7])[O:5][C:4](=[O:8])[NH:3]1.[C:9]1([CH2:15][CH2:16][C:17](Cl)=[O:18])[CH:14]=[CH:13][CH:12]=[CH:11][CH:10]=1.CN1CCOCC1>C(OCC)(=O)C>[C:9]1([CH2:15][CH2:16][C:17]([N:3]2[C@@H:2]([CH3:1])[C:6](=[O:7])[O:5][C:4]2=[O:8])=[O:18])[CH:14]=[CH:13][CH:12]=[CH:11][CH:10]=1Participants
5
Procedure
(S)-4-methyl-2,5-oxazolidinedione (L-alanine-NCA) (345 mg, 3 mmol) was dissolved in ethyl acetate (20 mL), followed by the addition of 3-phenylpropanoyl chloride (658 mg, 3.9 mmol) under ice cooling. Further, a solution of N-methyl-morpholine (394 mg, 3.9 mmol) in ethyl acetate (10 mL) was added dropwise under ice cooling over 20 minutes, and the resulting mixture was then stirred at the same temperature for 2 hours. The reaction mixture was treated in a similar manner as in Synthesis Process 5 of Example 8 to afford the title compound (408 mg, 55%) as a colorless clear syrup.
Workup
- additionThe reaction mixture was treated in a similar manner as in Synthesis Process 5 of Example 8
Sources & evidence
- ORD record
- ord-e4d415af27a24464a60ad98809652090
- Source dataset
- uspto-grants-2003_12
- Patent number
- US06670447B2
Reaction notes
Loading…